abstract |
The present invention relates to novel hepcidin antagonists of formula (I), pharmaceutical compositions comprising them, and in particular iron deficiency diseases and anemia, in particular anemia associated with chronic inflammatory disease (ACD; anemia of chronic disease and AI: anemia of inflammation) and their use as medicaments used in the treatment of disorders of iron metabolism. [Chemical 1] |